Literature DB >> 20416350

Plantaricin A, a peptide pheromone produced by Lactobacillus plantarum, permeabilizes the cell membrane of both normal and cancerous lymphocytes and neuronal cells.

Sverre L Sand1, Camilla Oppegård, Shinya Ohara, Toshio Iijima, Soheil Naderi, Heidi K Blomhoff, Jon Nissen-Meyer, Olav Sand.   

Abstract

Antimicrobial peptides produced by multicellular organisms protect against pathogenic microorganisms, whereas such peptides produced by bacteria provide an ecological advantage over competitors. Certain antimicrobial peptides of metazoan origin are also toxic to eukaryotic cells, with preference for a variety of cancerous cells. Plantaricin A (PlnA) is a peptide pheromone with membrane permeabilizing strain-specific antibacterial activity, produced by Lactobacillus plantarum C11. Recently, we have reported that PlnA also permeabilizes cancerous rat pituitary cells (GH(4) cells), whereas normal rat anterior pituitary cells are resistant. To investigate if preferential effect on cancerous cells is a general feature of PlnA, we have studied effects of the peptide on normal and cancerous lymphocytes and neuronal cells. Normal human B and T cells, Reh cells (from human B cell leukemia), and Jurkat cells (from human T cell leukemia) were studied by flow cytometry to detect morphological changes (scatter) and viability (propidium iodide uptake), and by patch clamp recordings to monitor membrane conductance. Ca(2+) imaging based on a combination of fluo-4 and fura-red was used to monitor PlnA-induced membrane permeabilization in normal rat cortical neurons and glial cells, PC12 cells (from a rat adrenal chromaffin tumor), and murine N2A cells (from a spinal cord tumor). All the tested cell types were affected by 10-100 microM PlnA, whereas concentrations below 10 microM had no significant effect. We conclude that normal and cancerous lymphocytes and neuronal cells show similar sensitivity to PlnA. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20416350     DOI: 10.1016/j.peptides.2010.04.010

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Construction, heterologous expression, partial purification, and in vitro cytotoxicity of the recombinant plantaricin E produced by Lactococcus lactis against Enteropathogenic Escherichia coli K.1.1 and human cervical carcinoma (HeLa) cells.

Authors:  Apon Zaenal Mustopa; Siti Mariyah; Sri Budiarti; Hidayah Murtiyaningsih; Wida Nurul Alfisyahrin
Journal:  Mol Biol Rep       Date:  2018-07-31       Impact factor: 2.316

2.  Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15.

Authors:  Yu-Ching Chen; Tsung-Lin Tsai; Xin-Hong Ye; Thy-Hou Lin
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10.

Authors:  Piyush Baindara; Ankur Gautam; G P S Raghava; Suresh Korpole
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

Review 4.  A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier?

Authors:  Leon M T Dicks; Leané Dreyer; Carine Smith; Anton D van Staden
Journal:  Front Microbiol       Date:  2018-09-28       Impact factor: 5.640

Review 5.  Bacterial Proteinaceous Compounds With Multiple Activities Toward Cancers and Microbial Infection.

Authors:  Gisele Rodrigues; Gislaine Greice Oliveira Silva; Danieli Fernanda Buccini; Harry Morales Duque; Simoni Campos Dias; Octávio Luiz Franco
Journal:  Front Microbiol       Date:  2019-08-06       Impact factor: 5.640

Review 6.  Bacteriocins as Potential Anticancer Agents.

Authors:  Sumanpreet Kaur; Sukhraj Kaur
Journal:  Front Pharmacol       Date:  2015-11-10       Impact factor: 5.810

Review 7.  Molecular and Cellular Mechanisms Influenced by Postbiotics.

Authors:  Rafał Jastrząb; Damian Graczyk; Pawel Siedlecki
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.